Literature DB >> 18059037

World disparities in risk definition and management of retinoblastoma: a report from the International Retinoblastoma Staging Working Group.

Guillermo L Chantada1, François Doz, Manuela Orjuela, Ibrahim Qaddoumi, Rita S Sitorus, Tomas Kepak, Anna Furmanchuk, Mauricio Castellanos, Tarun Sharma, Patricia Chevez-Barrios, Carlos Rodriguez-Galindo.   

Abstract

Following from the publication of the International Retinoblastoma Staging System, an open internet discussion group was created at the www.cure4kids.org resource. The results of a survey distributed among participants are discussed. Although most patients with retinoblastoma were treated under prospective protocols, there was a wide variation in the definition of risk criteria and in the criteria for giving adjuvant chemotherapy following enucleation. Definition of high-risk histological features and the criteria for use of adjuvant therapy will be standardized in future studies. Internet meetings are a valuable mechanism for enabling participation from under-resourced countries in the development of cooperative studies. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18059037     DOI: 10.1002/pbc.21427

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  6 in total

1.  Treatment of Nonmetastatic Unilateral Retinoblastoma in Children.

Authors:  Verónica Pérez; Claudia Sampor; Guadalupe Rey; Andreu Parareda-Salles; Katherine Kopp; Agustín P Dabezies; Gustavo Dufort; Marta Zelter; Juan P López; Marcelo Urbieta; Elisa Alcalde-Ruiz; Jaume Catala-Mora; Mariona Suñol; Diego Ossandon; Adriana C Fandiño; J Oscar Croxatto; María T G de Dávila; Gregory Reaman; Yaddanapudi Ravindranath; Guillermo L Chantada
Journal:  JAMA Ophthalmol       Date:  2018-07-01       Impact factor: 7.389

2.  Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.

Authors:  Patricia Chévez-Barrios; Ralph C Eagle; Mark Krailo; Jin Piao; Daniel M Albert; Yun Gao; Geeta Vemuganti; Mohammad Javed Ali; Vikas Khetan; Santosh G Honavar; Joan O'Brien; Ann-Marie Leahey; Katherine Matthay; Anna Meadows; Murali Chintagumpala
Journal:  J Clin Oncol       Date:  2019-09-20       Impact factor: 44.544

3.  Enucleation for retinoblastoma: the experience of a single center in Jordan.

Authors:  Iyad Sultan; Matthew W Wilson; Ibrahim Nawaiseh; Mustafa Mehyar; Saamir Kharma; Mohammed Al-Qudimat; Ribhi Hazin; Arwa Alalami; Imad Jaradat; Maysa Al-Husseini; Ghadeer Abdeen; Carlos Rodriguez-Galindo; Ibrahim Qaddoumi
Journal:  Int Ophthalmol       Date:  2010-04-28       Impact factor: 2.031

4.  In what circumstances is telemedicine appropriate in the developing world?

Authors:  Richard Wootton; Laurent Bonnardot
Journal:  JRSM Short Rep       Date:  2010-10-01

5.  Retinoblastoma: Recent trends A mini review based on published literature.

Authors:  Vikas Khetan; Aditi Gupta; Lingam Gopal
Journal:  Oman J Ophthalmol       Date:  2011-09

6.  Histopathological assessment of optic nerve invasion guided by radiological findings in enucleated globes with retinoblastoma.

Authors:  Mohammed M Abusayf; Hind M Alkatan; Sahar Elkhamary; Saleh A Almesfer; Azza M Y Maktabi
Journal:  BMC Ophthalmol       Date:  2020-09-29       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.